COMMUNIQUÉS West-GlobeNewswire

-
Cerevance Presents at The Federation of European Neuroscience Societies (FENS) Forum 2024
18/06/2024 - 14:30 -
Pressure BioSciences, Inc. to Host Business and Financial Update on Thursday, June 20th at 4:30pm ET
18/06/2024 - 14:16 -
Upswing Health and Hinge Health Partner to Address Care for Acute MSK Injuries for Joint Clients
18/06/2024 - 14:12 -
Novo Nordisk announces presentation of data from key semaglutide clinical trials in diabetes, obesity and chronic kidney disease at the 84th Scientific Sessions of the American Diabetes Association
18/06/2024 - 14:00 -
Daxor Corporation to Showcase the Benefits of BVA-100™ Guided-Care at the American Association of Heart Failure Nurses (AAHFN) 20th Annual Meeting
18/06/2024 - 14:00 -
CytomX Therapeutics to Present at the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Conference
18/06/2024 - 14:00 -
UroGen Pharma Announces Commencement of Public Offering of Ordinary Shares and Pre-Funded Warrants
17/06/2024 - 22:46 -
TerrAscend Announces Results of Annual General Meeting
17/06/2024 - 22:46 -
Veru Reminds Shareholders to Vote in Advance of Tomorrow’s Deadline for 2024 Annual Meeting of Shareholders
17/06/2024 - 22:45 -
Jasper Therapeutics to Present at the Oppenheimer Novel Targets in Immunology Summit
17/06/2024 - 22:30 -
Spectral AI to Participate in the Northland Capital Markets Virtual Growth Conference
17/06/2024 - 22:15 -
CytomX Therapeutics Promotes Chris Ogden to Chief Financial Officer
17/06/2024 - 22:15 -
GENFIT: New EASL-EASD-EASO Clinical Practice Guidelines for MASLD Include NIS2+® as Key Tool for Detecting At-Risk MASH
17/06/2024 - 22:10 -
GENFIT : Les nouvelles recommandations de pratique clinique de l'EASL-EASD-EASO pour la MASLD incluent NIS2+® comme outil-clé pour la détection de la MASH à risque
17/06/2024 - 22:10 -
Sienna Announces Renewal of Normal Course Issuer Bid
17/06/2024 - 22:10 -
Telomir Pharmaceuticals Scientific Advisor to Participate in Drug Information Association 2024 Global Annual Meeting Panel
17/06/2024 - 22:10 -
Autonomix Enhances Executive Leadership Team with Appointment of Proven Medical Technology Leader, Brad Hauser, as President and Chief Executive Officer
17/06/2024 - 22:05 -
Bionano Laboratories Announces New Category I CPT Code for OGM Use in Hematological Malignancy Analysis
17/06/2024 - 22:05 -
Oncocyte Appoints Andrea James as Chief Financial Officer
17/06/2024 - 22:05
Pages